Utah Medical Products Inc. reported a significant decrease in sales, gross profit, and net income for the second quarter of 2020 compared to the same period in 2019, primarily due to the COVID-19 pandemic's impact on elective medical procedures. Despite the challenges, the company maintained profitability and a solid financial position.
Second quarter sales decreased by 25.8% compared to the prior year due to the COVID-19 pandemic.
Gross profit declined by 34% due to increased manufacturing costs and lower absorption of overhead.
Operating income decreased by 56% due to lower sales and gross profit.
Net income decreased by 62.8% due to lower operating income and a deferred tax liability increase.
The company anticipates a potential recovery in OUS sales and focuses on managing costs and maintaining a strong financial position.
Analyze how earnings announcements historically affect stock price performance